Education
About Us
Working with TipRanks
Follow Us
Biolidics Ltd. (SG:8YY)
:8YY
8YY Stock Chart & Stats
S$0.02
<S$0.01(3.70%)
At close: 4:00 PM EST
S$0.02
<S$0.01(3.70%)
Day’s Range― - ―
52-Week Range<S$0.01 - S$0.03
Previous CloseN/A
Volume13.75M
Average Volume (3M)1.70M
Market Cap
S$39.87M
Enterprise ValueN/A
Total Cash (Recent Filing)S$300.00K
Total Debt (Recent Filing)S$2.52M
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Oct 29, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding1,733,441,800
10 Day Avg. Volume589,960
30 Day Avg. Volume1,701,833
Financial Highlights & Ratios
PEG Ratio0.50
Price to Book (P/B)16.43
Price to Sales (P/S)36.30
P/FCF Ratio-12.27
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Biolidics Ltd. News
8YY FAQ
What was Biolidics Ltd.’s price range in the past 12 months?
Biolidics Ltd. lowest share price was <S$0.01 and its highest was S$0.03 in the past 12 months.
What is Biolidics Ltd.’s market cap?
Biolidics Ltd.’s market cap is S$39.87M.
When is Biolidics Ltd.’s upcoming earnings report date?
Biolidics Ltd.’s upcoming earnings report date is Oct 29, 2025 which is yesterday.
How were Biolidics Ltd.’s earnings last quarter?
Biolidics Ltd. released its earnings results on Aug 12, 2025. The company reported S$0 earnings per share for the quarter, the consensus estimate of N/A by S$0.
Is Biolidics Ltd. overvalued?
According to Wall Street analysts Biolidics Ltd.’s price is currently Overvalued.
Does Biolidics Ltd. pay dividends?
Biolidics Ltd. does not currently pay dividends.
What is Biolidics Ltd.’s EPS estimate?
Biolidics Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Biolidics Ltd. have?
Biolidics Ltd. has 1,733,441,800 shares outstanding.
What happened to Biolidics Ltd.’s price movement after its last earnings report?
Biolidics Ltd. reported an EPS of S$0 in its last earnings report, expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Biolidics Ltd.?
Currently, no hedge funds are holding shares in SG:8YY
Company Description
Biolidics Ltd.
Embracing Future Holdings Limited, a precision medicine medical technology company, focuses on developing a portfolio of diagnostic solutions in Japan, Hong Kong, Thailand, Malaysia, and the United States. It operates through Cancer, Infectious Diseases, and Laboratory Services segments. The company offers ClearCell FX1 System that includes Streck Cell-free DNA BCT and EDTA tubes, a fully automated device for cell retrieval that can separate wholly intact and viable circulating tumour cells, or CTCs from small amounts of blood; and CTChip FR1 biochip that isolate the CTCs from leukocytes. It also provides laboratory services. The company was formerly known as Biolidics Limited and changed its name to Embracing Future Holdings Limited in June 2025. The company was incorporated in 2009 and is based in Singapore.
Technical Analysis
HC Surgical Specialists Ltd
―
Hyphens Pharma International Ltd.
―
iX Biopharma Ltd.
―
VicPlas International Ltd.
―
Singapore Paincare Holdings Limited
―
Options Prices
Currently, No data available
---